Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes
These include ashwagandha, bladderwrack, caffeine (including green tea and ginseng), and certain over-the-counter products designed to increase focus and energy
Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
How Often to Use: Receive up to 3,000mg within 28 days